跳至主要内容
临床试验/EUCTR2011-005666-37-IT
EUCTR2011-005666-37-IT进行中(未招募)不适用

Evaluation of the effect exerted by 5-methyltetrahydrofolate (5-MTHF) and folic acid in postmenopausal women - PrefoDIP

ZAMBON ITALIA0 个研究点开始时间: 2012年12月12日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • -Postmenopausal women with age between 45 and 55 at screening; - Women with plasmatic folate levels not superior than 5 ng/ml as assessed in the screening visit; -Women who have no intention of taking hormone replacement therapy -; -BMI between 19 and 30; -Good physical health and mental health; -Willingness to sign the informed consent form.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Severe hypertension therapy. -Patients who smoke -Presence or history of significant liver disease until the liver function tests are not back to normal; -Presence or history of liver tumors (benign or malignant); -Malignant neoplasms, known or suspected; -Hypersensitivity to the active substance or excipients of the drug under study.

研究者

发起方
ZAMBON ITALIA

相似试验